Avidity Partners Management LP Sells 308,381 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Avidity Partners Management LP lessened its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 38.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 489,119 shares of the specialty pharmaceutical company’s stock after selling 308,381 shares during the quarter. Jazz Pharmaceuticals […]

Related Keywords

United States ,Canada ,Neenam Patil , ,News Ratings For Jazz Pharmaceuticals Daily ,Jpmorgan Chase Co ,Nasdaq ,Pathstone Family Office ,Vanguard Personalized Indexing Management ,Jazz Pharmaceuticals Profile ,Cantor Fitzgerald ,Jazz Pharmaceuticals ,Royal Bank ,Needham Company ,Securities Exchange Commission ,Insider Activity At Jazz Pharmaceuticals ,Jazz Pharmaceuticals Stock ,Charles Schwab Investment Management Inc ,Janney Montgomery Scott ,Quarter For Jazz Pharmaceuticals ,Goldman Sachs Group ,Avidity Partners Management ,Free Report ,Partners Management ,Wealth Management ,Montgomery Scott ,Schwab Investment Management ,Personalized Indexing Management ,Get Free Report ,Exchange Commission ,Jazz Pharmaceuticals Daily ,